{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:14:17Z","timestamp":1770498857722,"version":"3.49.0"},"reference-count":18,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1242,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[1998,8]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Proton pump inhibitors have been widely used in combination with amoxycillin, clarithromycin or metronidazole for the treatment of <jats:italic>Helicobacter pylori<\/jats:italic> infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim:<\/jats:title><jats:p>To study the effects of 1\u2010week ranitidine bismuth citrate (RBC)\u2010based triple therapy in the treatment of <jats:italic>H. pylori\u2010<\/jats:italic>related duodenal ulcers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method:<\/jats:title><jats:p>Patients with duodenal ulcers and <jats:italic>H. pylori<\/jats:italic> infection were prospectively randomized to receive either RBC with amoxycillin and clarithromycin for 1 week (RAC), or omeprazole with amoxycillin and clarithromycin for 1 week (OAC). No additional ulcer healing drug was used after the 1\u2010week medication. Patients were assessed for <jats:italic>H. pylori<\/jats:italic> eradication, ulcer healing and side\u2010effects after receiving the therapies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>One hundred consecutive patients were recruited to this study, with 50 patients randomized to each treatment group. In the intention\u2010to\u2010treat analysis, duodenal ulcers were completely healed in 45 (90%) patients in the RAC group and 43 (89.6%) in the OAC group (<jats:italic>P<\/jats:italic>\u2003=\u20031.0). <jats:italic>H. pylori<\/jats:italic> eradication was confirmed in 47 (94%) in the RAC group and 42 (87.5%) in the OAC group (<jats:italic>P<\/jats:italic>\u2003=\u20030.31). There was no significant difference in the severity of side\u2010effects experienced by the two treatment groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>One\u2010week RBC\u2010based triple therapy is an effective treatment for <jats:italic>H. pylori<\/jats:italic>\u2010related duodenal ulcers. The therapeutic effects are comparable to a 1\u2010week course of proton pump inhibitor\u2010based triple therapy.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.1998.00367.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:37:08Z","timestamp":1047353828000},"page":"725-730","source":"Crossref","is-referenced-by-count":32,"title":["One\u2010week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of <i>Helicobacter pylori<\/i>\u2010related duodenal ulcer"],"prefix":"10.1111","volume":"12","author":[{"family":"Sung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Yung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)80003-0"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.8"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00027.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0953-0673.1996.00241.x"},{"key":"e_1_2_6_6_2","article-title":"High cure rates with ranitidine bismuth citrate (Pylorid) plus clarithromycin given twice daily","volume":"39","author":"Bardhan KD","year":"1996","journal-title":"Gut"},{"key":"e_1_2_6_7_2","article-title":"GR 122311X (ranitidine bismuth citrate) with clarithromycin for the eradication of Helicobacter pylori","volume":"37","author":"Pounder RE","year":"1995","journal-title":"Gut"},{"key":"e_1_2_6_8_2","article-title":"Ranitidine bismuth citrate in combination with clarithromycin either 250 mg qds or 500 mg bd eradicates Helicobacter pylori in up to 96% of patients with active duodenal ulcer disease","volume":"39","author":"Lancaster Smith MJ","year":"1996","journal-title":"Gut"},{"key":"e_1_2_6_9_2","article-title":"Randomized comparison of ranitidine bismuth citrate\u2010based triple therapies for H. pylori","volume":"112","author":"Laine L","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_6_10_2","article-title":"High H. pylori eradication rate with one\u2010week triple regimen containing bismuth ranitidine citrate","volume":"41","author":"Gudjonsson H","year":"1997","journal-title":"Gut"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00009.x"},{"key":"e_1_2_6_12_2","article-title":"MACH II study: Helicobacter pylori resistance to antimicrobial agents and its influence on clinical outcome","volume":"112","author":"Megraud F","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_6_13_2","article-title":"Helicobacter pylori positive duodenal ulcer treated with omeprazole vs. ranitidine bismuth citrate triple therapy","volume":"41","author":"Catalano F","year":"1997","journal-title":"Gut"},{"key":"e_1_2_6_14_2","article-title":"Lansoprazole or RBC based triple therapy for H. pylori eradication. Results of an open randomized study","volume":"41","author":"Spadacinni A","year":"1997","journal-title":"Gut"},{"key":"e_1_2_6_15_2","article-title":"A seven\u2010day regimen with RBC plus amoxicillin and clarithromycin is effective in eradicating H. pylori and healing duodenal ulcer","volume":"41","author":"Marchi S","year":"1997","journal-title":"Gut"},{"key":"e_1_2_6_16_2","article-title":"Assessment of the efficacy and safety of three 7 day eradication regimens containing RBC. Results of an Italian study","volume":"41","author":"Cannizzaro O","year":"1997","journal-title":"Gut"},{"key":"e_1_2_6_17_2","article-title":"Antimicrobial resistance of Helicobacter pylori in Korean duodenal ulcer patients","volume":"112","author":"Han DS","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_6_18_2","article-title":"The prevalence of the drug resistance in Helicobacter pylori and the effects of the resistance on the eradication therapy in Japan","volume":"112","author":"Miyaji H","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_6_19_2","article-title":"Ranitidine bismuth citrate enhances clarithromycin activity against clinical isolates of H. pylori","volume":"112","author":"Osato MS","year":"1997","journal-title":"Gastroenterology"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1998.00367.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1998.00367.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.1998.00367.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T06:59:27Z","timestamp":1694415567000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.1998.00367.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,8]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1998,8]]}},"alternative-id":["10.1046\/j.1365-2036.1998.00367.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.1998.00367.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,8]]}}}